Understanding Protein Formulation Development Processes

By Stacey Burt


In medical circles, preparation and formulation of a new drug is not an easy task. However it still has to be undertaken since the lives of patients depend on it. These form the basis of protein formulation development which is the process tasked with combining two or more elements to form a drug for a given medical purpose.

Formulation studies involve developing a preparation of the drug which is both stable and acceptable to the patient. For orally taken drugs, this usually involves incorporating the drug into a tablet or a capsule. However, a tablet contains a variety of other substances apart from the drug itself, and studies have to be carried out to ensure that the drug is compatible with these other substances

Proteins are known to have complex structures. These structures also have the characteristic of being delicate and easily change when subjected to clinical tests. Hence they require specialized attention to ensure these inevitable changes do not alter the performance of end product. Therefore, adequate resources must be available for these extra care.

Sufficient shelf life needs to be determined under conditions to which the product will be exposed in the system of a patient. This however is not applicable as the shelf life of a pure protein strand is hard to achieve. The purification process is tasking and is requisite of a lot of resources, which would render the efforts of creating the drug uneconomical.

Maintaining the integrity of this protein would be difficult, even with the extraction of pure strands. The shelf life would be drastically reduced and the instability of the same heightened. The processes of handling and transportation and delivery would need to be done with extreme caution. However, the strand would have the advantage of having neither chemical nor physical change.

The structure of this protein itself is a limiting factor. The three dimensional and naturally delicate nature also keep researchers from easily achieving purity and stability of the strand. In this case, the formulations have to be developed with the allowance that there will be inevitable chemical changes in the nature of particular protein.

Safety should always be a concern during the formulation development process. Proper maintenance of this strand will be key to maintain the stature of protein during testing, development, handling and transportation of substance. Appropriate Safety and storage mechanisms should be in place to ensure the viability is preserved.

Various methodical studies need to be carried out to ensure full compliance with regulatory requirements for registration. However, the challenge is that it takes a year or two to collect the results. For efficiency purposes, the commercial formulation should continue in the process of development while preclinical studies and clinical trials are underway.

With these levels of advancement in the process of protein formulations development, regulatory framework limitations, as well as the challenges facing the medics and the process entirely, it is not easy to propagate such experiences to the real world to produce drugs for every need. There must be more research and development towards eliminating such barriers.




About the Author:



No comments:

Post a Comment